Welcome to our dedicated page for Chemours Co news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours Co stock.
Chemours Co (CC) delivers essential chemical solutions through its titanium technologies, fluoroproducts, and advanced performance materials. This news hub provides investors and industry professionals with timely updates on strategic developments shaping the company’s role in coatings, refrigeration, and industrial innovation.
Access authoritative coverage of Chemours’ financial announcements, product innovations, and operational milestones. Track critical updates including quarterly earnings, sustainability initiatives, and regulatory developments alongside analysis of market positioning in the chemical sector.
Our curated news collection features press releases on titanium dioxide advancements, breakthroughs in low-global-warming refrigerants like Opteon™, and partnerships driving next-generation materials for electric vehicles and data center cooling. Stay informed on leadership changes, patent filings, and industry recognition impacting Chemours’ global operations.
Bookmark this page for streamlined access to verified updates on CC’s technological advancements and financial performance. Combine real-time alerts with historical context to assess the company’s evolving market strategy.
On August 18, 2021, The Chemours Company (NYSE: CC) announced the successful completion of a private offering of $650 million in 4.625% senior unsecured notes due 2029. The proceeds will primarily fund the cash tender offer for its outstanding 7.000% senior notes due 2025. These notes are exempt from registration under the Securities Act, being offered only to qualified institutional buyers. The offering is expected to optimize Chemours' debt structure, addressing existing obligations efficiently.
The Chemours Company (NYSE: CC) announced early tender results for its cash tender offer to purchase all outstanding 7.000% senior notes due 2025. As of August 17, 2021, approximately $462 million of the $750 million notes were tendered, representing 61.61% of the outstanding amount. The offer includes an early tender payment of $30 per $1,000 principal amount. The tender offer will expire on August 31, 2021, unless extended. Consents were received from a majority of note holders, enabling proposed amendments to the indenture to shorten notice periods for redemption.
The Chemours Company (NYSE: CC) has announced a private offering of $650 million in 4.625% senior unsecured notes due 2029, expected to close by August 18, 2021. The proceeds will primarily be used to fund the purchase of its existing 7.000% senior notes due 2025 through a cash tender offer. These notes will not be registered under the Securities Act and will be offered only to qualified institutional buyers. This transaction aims to optimize Chemours' debt structure.
The Chemours Company (NYSE: CC) has initiated a cash tender offer for its outstanding 7.000% senior notes due 2025, with an aggregate principal amount of $750 million. The offer includes a consent solicitation for amendments to the indenture, aiming to shorten notice periods for optional redemptions. The tender offer will expire at midnight on August 31, 2021. Early tendering by August 17 will yield greater consideration. The offer is contingent upon the completion of a New Debt Financing and obtaining requisite consents. Chemours has also issued a notice of redemption for any remaining notes after the offer.
The Chemours Company (NYSE: CC) announced plans for a private offering of $650 million in fixed-rate senior unsecured notes. The proceeds will primarily fund the purchase of existing 7.000% senior notes due 2025 as part of a cash tender offer. The offering is exempt from federal registration requirements and targets qualified institutional buyers and non-U.S. persons. Chemours emphasizes that this is not an offer or solicitation in jurisdictions where it would be unlawful. The company continues to navigate challenges posed by the COVID-19 pandemic, which affects its operations and financial outlook.
The Chemours Company (NYSE: CC) reported impressive second quarter 2021 results with net sales of $1.7 billion, a 51% increase year-over-year. The net income stood at $66 million with an EPS of $0.39. Adjusted net income soared to $205 million and adjusted EPS reached $1.20, marking a significant $1.02 increase year-over-year. Free cash flow improved to $189 million, up $139 million year-over-year. The company also approved a $0.25 dividend per share for Q3 2021 and anticipates strong performance for the remainder of the year.
The Chemours Company (NYSE: CC) declared a quarterly cash dividend of $0.25 per share for Q3 2021, payable on September 15, 2021, to stockholders of record by August 16, 2021.
Chemours specializes in Titanium Technologies and various chemical solutions for diverse market sectors.
The Chemours Company (NYSE: CC) has announced a definitive agreement to sell its Mining Solutions business to Draslovka Holding a.s. for $520 million in cash, equating to 10 times 2020 Adjusted EBITDA. The transaction, expected to close in Q4 2021 pending regulatory approvals, aligns with Chemours' strategy to focus on its primary business sectors. Chemours President, Mark Newman, stated this move is aimed at enhancing long-term shareholder value. Additionally, the deal marks Draslovka's first significant U.S. investment.
The Chemours Company (NYSE: CC) recently initiated the construction of a $93 million mining facility in Clay County, Florida. This site will utilize innovative Mobile Mining Units (MMUs) that minimize environmental impact compared to traditional mining methods. The project aims to enhance access to titanium and zircon mineral sands, crucial for producing Ti-Pure™ titanium dioxide. The expansion is expected to create 50-75 jobs with competitive wages and underscores Chemours' commitment to sustainability. Construction commenced in July 2021, with operations anticipated to start by late 2022.
